| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.011 | 0.8 |